Epsilon Healthcare Ltd - Asset Resilience Ratio

Latest as of June 2023: 1.69%

Epsilon Healthcare Ltd (EPN) has an Asset Resilience Ratio of 1.69% as of June 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read how much debt does Epsilon Healthcare Ltd carry for a breakdown of total debt and financial obligations.

Liquid Assets

AU$301.46K

≈ $213.30K USD Cash + Short-term Investments

Total Assets

AU$17.82 Million

≈ $12.61 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2019)

This chart shows how Epsilon Healthcare Ltd's Asset Resilience Ratio has changed over time. See EPN net assets for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Epsilon Healthcare Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see EPN market cap overview.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	AU$301.46K	1.69%
Short-term Investments	AU$0.00	0%
Total Liquid Assets	AU$301.46K	1.69%

Asset Resilience Insights

Limited Liquidity: Epsilon Healthcare Ltd maintains only 1.69% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Epsilon Healthcare Ltd Industry Peers by Asset Resilience Ratio

Compare Epsilon Healthcare Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Jiangsu Hengrui Medicine Co Ltd SHG:600276	Drug Manufacturers - Specialty & Generic	0.16%
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Drug Manufacturers - Specialty & Generic	1.54%
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt F:RIG2	Drug Manufacturers - Specialty & Generic	0.20%
Regencell Bioscience Holdings Ltd NASDAQ:RGC	Drug Manufacturers - Specialty & Generic	43.05%
Shan Dong Dong-E E-Jiao Co Ltd SHE:000423	Drug Manufacturers - Specialty & Generic	20.44%
Beijing New Oriental Star Petrochemical Engineering Co Ltd SHE:002755	Drug Manufacturers - Specialty & Generic	24.59%
Henan Newland Pharmaceutical Co. Ltd. A SHE:301277	Drug Manufacturers - Specialty & Generic	31.63%
Hainan Shuangcheng Pharmaceut SHE:002693	Drug Manufacturers - Specialty & Generic	3.29%

Annual Asset Resilience Ratio for Epsilon Healthcare Ltd (2016–2019)

The table below shows the annual Asset Resilience Ratio data for Epsilon Healthcare Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2019-12-31	12.77%	AU$3.55 Million ≈ $2.51 Million	AU$27.81 Million ≈ $19.68 Million	-6.57pp
2018-12-31	19.34%	AU$6.33 Million ≈ $4.48 Million	AU$32.75 Million ≈ $23.17 Million	-30.95pp
2017-12-31	50.29%	AU$11.04 Million ≈ $7.81 Million	AU$21.95 Million ≈ $15.53 Million	+42.57pp
2016-12-31	7.73%	AU$885.37K ≈ $626.46K	AU$11.46 Million ≈ $8.11 Million	--

pp = percentage points

About Epsilon Healthcare Ltd

AU:EPN Australia Drug Manufacturers - Specialty & Generic

Market Cap

$5.51 Million

AU$7.78 Million AUD

Market Cap Rank

#28158 Global

#1534 in Australia

Share Price

AU$0.02

Change (1 day)

+0.00%

52-Week Range

AU$0.02 - AU$0.04

All Time High

AU$1.08